AzTrials
AzTrials

StrokeNCT05806658

A Theory-driven Visual Arts-based Intervention for Community-dwelling Stroke Survivors

A study testing Visual arts-based intervention in people with Stroke and Psychosocial Problem, run by The Nethersole School of Nursing at 1 site in Macau.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Stroke leads to psychosocial issues for community-dwelling stroke survivors in their recovery journey. Previous studies showed the benefits of visual arts-based interventions in enhancing self-efficacy and psychosocial functions. However, the interventions were not well designed with a theoretical framework. Read more about this study

Who is it for?
Any age
Conditions the study is for
Stroke, Psychosocial Problem
What is being tested?
Visual arts-based intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
1 siteMacau
Study dates
18 Sep 2023to 8 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Aged 18 years old or above
  • A clinical diagnosis of first-ever or recurrent ischaemic or haemorrhagic stroke
  • At least three months after stroke onset
  • Living at home
  • Hong Kong Montreal Cognitive Assessment (HK-MoCA) above the second percentile
  • At least stage four of upper limb function was assessed by Brunnstrom recovery stages (BRS)
Show all 10Show fewer
  • Able to remain in a sitting position on a chair or wheelchair independently or with support
  • Able to communicate with Cantonese or Putonghua
  • Able to read traditional or simplified Chinese
  • Able to provide written informed consent

Who cannot join

  • Other diagnoses or diseases causing pre-existing physical disability or psychosocial problems
  • Dysphasia, hearing, or visual impairments
  • Any substance abuse affected their health status
  • Already taken a visual arts-based intervention for stroke recovery
  • Currently taking part in other research for psychosocial recovery
  • Currently receiving psychosocial therapy or intervention

Trial locations and contacts

1 site in 1 country.

Macau1 site
  • Pou Tai Elderly Service

    Macao, 999078

About this study

Official title: A Theory-driven Visual Arts-based Intervention on Psychosocial Outcomes Among Community-dwelling Chinese Stroke Survivors

Stroke leads to psychosocial issues for community-dwelling stroke survivors in their recovery journey. Previous studies showed the benefits of visual arts-based interventions in enhancing self-efficacy and psychosocial functions. However, the interventions were not well designed with a theoretical framework. This study will evaluate the effectiveness of a theory-driven visual arts-based intervention on community-dwelling stroke survivors' psychosocial outcomes. A two-arm randomised controlled trial will be conducted to test the effects of this intervention and assess its feasibility in the community.

Read the detailed description

Stroke is the second-leading cause of death and the major cause of disability worldwide. With advanced progress in stroke treatment, more people with stroke now survive longer than in past decades and become stroke survivors living in the community. Improvements in stroke rehabilitation services further boost physical outcomes and increase functional independence in stroke survivors after discharge. Whereas psychosocial issues commonly persist over the recovery journey in community-dwelling stroke survivors, such as psychological distress, low self-efficacy and reduction in social participation.

Existing research suggested that enhancing self-efficacy is important to post-stroke psychosocial recovery, while the benefits of visual arts-based interventions in promoting post-stroke psychosocial functions have also been found. However, the current visual arts-based interventions were not well designed with a theoretical framework. Thus, this study will be conducted to contribute to current knowledge of the effectiveness of visual arts-based intervention grounded on Bandura's Self-Efficacy Theory on community-dwelling stroke survivors.

This current study will be conducted as a two-arm randomised controlled trial. Eligible participants will be randomised into either a four-week visual arts-based intervention group or a usual stroke care control group. The control group will continue with the usual stroke care provided by community healthcare services. Participants will be assessed 3 times at baseline (T0), post-intervention (T1), and one-month post-intervention (T2).

Being tested
Visual arts-based intervention
Keywords
Stroke, Psychosocial functioning, Self-Efficacy
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Visual arts-based interventionOther

    This visual arts-based intervention is grounded on Bandura's Self-Efficacy Theory. It consists of four weekly group and face-to-face sessions delivered by a qualified facilitator. The contents of the intervention involve structured visual art-making activity, group discussion, and workbook assistance.

Study groups in NCT05806658
Study groupRoleWhat they receive
Intervention groupExperimentalEligible participants will be randomly assigned to receive usual care with the four-week visual arts-based intervention.
Receives: Other: Visual arts-based intervention
Control groupNo interventionEligible participants will be randomly assigned to receive usual stroke care.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. General Self-efficacy as assessed by the General Self-efficacy Scale (Chinese version)

    The General Self-efficacy Scale (Chinese version) (C-GSES) will be adopted to measure the participants' self-efficacy. Each item asks participants about their self-efficacy. Each item is rated on a four-point scale from 1 "Not at all true" to 4 "Exactly True". The total score is summed to give a range from 10 to 40, and the higher score represents greater self-efficacy. The C-GSES has a high Cronbach's alpha coefficient of 0.96, which indicates good reliability and validity.

    Measured: Change from baseline (T0) to immediately after completion of the intervention (T1), and one month after completion of the intervention (T2)

Secondary outcomes (3)
  1. Psychological distress (Depression, anxiety, and stress) as assessed by the Depression Anxiety and Stress Scale 21-items (Chinese version)

    The Depression Anxiety and Stress Scale 21-items (Chinese version) (C-DASS-21) will be adopted to measure participants' psychological distress. The score calculates the stress, depressive symptoms, and anxiety in five-level in each subscale: (1) normal; (2) mild; (3) moderate; (4) severe; and (5) extremely severe. The higher scores represent more negative moods. The total scale has a Cronbach's alpha coefficient of 0.92, and the depression, anxiety, and stress subscales have a Cronbach's alpha coefficient of 0.83, 0.80, and 0.82, respectively, which indicates good reliability and validity.

    Measured: Change from baseline (T0) to immediately after completion of the intervention (T1), and one month after completion of the intervention (T2)

  2. Social participation as assessed by the social domain Stroke Impact Scale 3.0 (Mandarin version)

    The social domain Stroke Impact Scale 3.0 (Mandarin version) (M-SIS 3.0) will be adopted to measure participants' social participation. The score of each item in the social domain is from 1 "all of the time" to 5 "none of the time". The final score of this subscale ranges from 8 to 40. The higher the total score means the better social participation. The total scale has a Cronbach's alpha coefficient of 0.78, and the social domain has a Cronbach's alpha coefficient of 0.83, which indicates good reliability.

    Measured: Change from baseline (T0) to immediately after completion of the intervention (T1), and one month after completion of the intervention (T2)

  3. Health-related quality of life as assessed by the World Health Organization Quality of Life-BREF (Chinese version)

    The World Health Organization Quality of Life-BREF (Chinese version) (C-WHOQOL-BREF) will be adopted to measure participants' quality of life. This scale consists of 26 items: Two items assess the overall quality of life and general health, and the remaining 24 items were categorised into four domains, including physical health, psychological health, social relationships, and environment. The items are scored from 1 to 5. The average score for each area is between 4 and 20. The higher the total score means the better the quality of life. The C-WHOQOL-BREF has a high Cronbach's alpha coefficient of 0.64 to 0.88, which indicates good reliability and validity.

    Measured: Change from baseline (T0) to immediately after completion of the intervention (T1), and one month after completion of the intervention (T2)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Apr 2023
  2. Study start18 Sep 2023
  3. Primary completion14 Dec 2024
  4. Study completion8 Apr 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel randomised controlled trial
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
144 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05806658
Sponsor's protocol ID
20230325-004-000
Status last verified
Sep 2025
First submitted
28 Mar 2023
Last updated
11 Sep 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Visual arts-based intervention in people with Stroke and Psychosocial Problem, run by The Nethersole School of Nursing at 1 site in Macau.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Macau. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

General Self-efficacy as assessed by the General Self-efficacy Scale (Chinese version) (time frame: Change from baseline (T0) to immediately after completion of the intervention (T1), and one month after completion of the intervention (T2)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in